Close Menu

NEW YORK (GenomeWeb) – NeoGenomics and Definiens announced today that they have expanded their cancer biomarker discovery alliance to include the development and automation of assays for clinical trials and clinical testing.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

May
10
Sponsored by
MeMed

Amid the COVID-19 pandemic, hospitals and intensive care units around the world have been overwhelmed by unprecedented levels of demand.